rs17816260
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_013372.7(GREM1):c.*239A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.56 in 564,408 control chromosomes in the GnomAD database, including 92,051 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.49 ( 20292 hom., cov: 31)
Exomes 𝑓: 0.59 ( 71759 hom. )
Consequence
GREM1
NM_013372.7 3_prime_UTR
NM_013372.7 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.939
Publications
11 publications found
Genes affected
GREM1 (HGNC:2001): (gremlin 1, DAN family BMP antagonist) This gene encodes a member of the BMP (bone morphogenic protein) antagonist family. Like BMPs, BMP antagonists contain cystine knots and typically form homo- and heterodimers. The CAN (cerberus and dan) subfamily of BMP antagonists, to which this gene belongs, is characterized by a C-terminal cystine knot with an eight-membered ring. The antagonistic effect of the secreted glycosylated protein encoded by this gene is likely due to its direct binding to BMP proteins. As an antagonist of BMP, this gene may play a role in regulating organogenesis, body patterning, and tissue differentiation. In mouse, this protein has been shown to relay the sonic hedgehog (SHH) signal from the polarizing region to the apical ectodermal ridge during limb bud outgrowth. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
GREM1 Gene-Disease associations (from GenCC):
- hereditary mixed polyposis syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
- polyposis syndrome, hereditary mixed, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 15-32731484-A-C is Benign according to our data. Variant chr15-32731484-A-C is described in ClinVar as Benign. ClinVar VariationId is 1278747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.748 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GREM1 | NM_013372.7 | c.*239A>C | 3_prime_UTR_variant | Exon 2 of 2 | ENST00000651154.1 | NP_037504.1 | ||
| GREM1 | NM_001368719.1 | c.*239A>C | 3_prime_UTR_variant | Exon 2 of 2 | NP_001355648.1 | |||
| GREM1 | NM_001191323.2 | c.*239A>C | 3_prime_UTR_variant | Exon 3 of 3 | NP_001178252.1 | |||
| GREM1 | NM_001191322.2 | c.*239A>C | 3_prime_UTR_variant | Exon 3 of 3 | NP_001178251.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GREM1 | ENST00000651154.1 | c.*239A>C | 3_prime_UTR_variant | Exon 2 of 2 | NM_013372.7 | ENSP00000498748.1 | ||||
| GREM1 | ENST00000652365.1 | c.*239A>C | 3_prime_UTR_variant | Exon 2 of 2 | ENSP00000498763.1 | |||||
| GREM1 | ENST00000560830.1 | c.*239A>C | 3_prime_UTR_variant | Exon 3 of 3 | 2 | ENSP00000453141.1 | ||||
| GREM1 | ENST00000560677.5 | c.*544A>C | downstream_gene_variant | 4 | ENSP00000453387.1 |
Frequencies
GnomAD3 genomes AF: 0.492 AC: 74641AN: 151780Hom.: 20289 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
74641
AN:
151780
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.586 AC: 241589AN: 412510Hom.: 71759 Cov.: 2 AF XY: 0.589 AC XY: 126261AN XY: 214492 show subpopulations
GnomAD4 exome
AF:
AC:
241589
AN:
412510
Hom.:
Cov.:
2
AF XY:
AC XY:
126261
AN XY:
214492
show subpopulations
African (AFR)
AF:
AC:
2720
AN:
11328
American (AMR)
AF:
AC:
7531
AN:
14402
Ashkenazi Jewish (ASJ)
AF:
AC:
7580
AN:
12780
East Asian (EAS)
AF:
AC:
20004
AN:
28302
South Asian (SAS)
AF:
AC:
21943
AN:
35856
European-Finnish (FIN)
AF:
AC:
25116
AN:
41024
Middle Eastern (MID)
AF:
AC:
1066
AN:
1822
European-Non Finnish (NFE)
AF:
AC:
141970
AN:
243210
Other (OTH)
AF:
AC:
13659
AN:
23786
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
4711
9422
14132
18843
23554
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
678
1356
2034
2712
3390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.492 AC: 74662AN: 151898Hom.: 20292 Cov.: 31 AF XY: 0.499 AC XY: 37019AN XY: 74240 show subpopulations
GnomAD4 genome
AF:
AC:
74662
AN:
151898
Hom.:
Cov.:
31
AF XY:
AC XY:
37019
AN XY:
74240
show subpopulations
African (AFR)
AF:
AC:
10085
AN:
41416
American (AMR)
AF:
AC:
7975
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
2102
AN:
3470
East Asian (EAS)
AF:
AC:
3934
AN:
5120
South Asian (SAS)
AF:
AC:
2991
AN:
4802
European-Finnish (FIN)
AF:
AC:
6450
AN:
10564
Middle Eastern (MID)
AF:
AC:
170
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39442
AN:
67938
Other (OTH)
AF:
AC:
1098
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1734
3469
5203
6938
8672
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
668
1336
2004
2672
3340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2225
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.